A 45-year-old female patient received oral methimazole and propylthiouracil for hyperthyroidism. The drug was discontinued 2 weeks later due to methimazole-induced agranulocytosis. About 1 month later, the patient was re-given methimazole 10 mg thrice daily according to the doctor′s instructions and advice. She developed high fever and chills about 2 hours after the first administration and half on after the second administration, respectively, with a maximum body temperature of 39.5 ℃. The laboratory tests showed WBC 5.99×10 9/L, neutrophil 0.91, C-reactive protein 2.3 mg/L, and negative bacterial blood culture. Drug fever caused by methimazole was considered. Methimazole was stopped and symptomatic treatment was given. Four and a half hours later, the patient′s body temperature dropped to 36.5 ℃. At 1 year of follow-up, the patient did not take methimazole again, and neither high fever nor chills recurred.

A 45-year-old female patient received oral methimazole and propylthiouracil for hyperthyroidism. The drug was discontinued 2 weeks later due to methimazole-induced agranulocytosis. About 1 month later, the patient was re-given methimazole 10 mg thrice daily according to the doctor′s instructions and advice. She developed high fever and chills about 2 hours after the first administration and half on after the second administration, respectively, with a maximum body temperature of 39.5 ℃. The laboratory tests showed WBC 5.99×10 9/L, neutrophil 0.91, C-reactive protein 2.3 mg/L, and negative bacterial blood culture. Drug fever caused by methimazole was considered. Methimazole was stopped and symptomatic treatment was given. Four and a half hours later, the patient′s body temperature dropped to 36.5 ℃. At 1 year of follow-up, the patient did not take methimazole again, and neither high fever nor chills recurred.

BACKGROUND: Curcumin, a yellow ingredient of turmeric (Curcuma longa Linn, Zingiberaceae), has long been used in traditional folk medicine in the management of inflammatory disorders. Although curcumin has been reported to inhibit experimentally-induced colitis and carcinogenesis, the underlying molecular mechanisms remain largely unresolved. METHODS: Murine colitis was induced by dextran sulfate sodium (DSS) which mimics inflammatory bowel disease. Curcumin or tetrahydrocurcumin was given orally (0.1 or 0.25 mmol/kg body weight daily) for 7 days before and together with DSS administration (3% in tap water). Collected colon tissue was used for histologic and biochemical analyses. RESULTS: Administration of curcumin significantly attenuated the severity of DSS-induced colitis and the activation of NF-κB and STAT3 as well as expression of COX-2 and inducible nitric oxide synthase. In contrast to curcumin, its non-electrophilic analogue, tetrahydrocurcumin has much weaker inhibitory effects. CONCLUSIONS: Intragastric administration of curcumin inhibited the experimentally induced murine colitis, which was associated with inhibition of pro-inflammatory signaling mediated by NF-κB and STAT3.
Animals ; Body Weight ; Carcinogenesis ; Colitis ; Colon ; Curcuma ; Curcumin ; Dextran Sulfate ; Dextrans ; Inflammatory Bowel Diseases ; Medicine, Traditional ; Mice ; Nitric Oxide Synthase Type II

Objective To observe the clinical effect of combination of clopidogrel and simvastatin on coro-nary heart disease and transient ischemic attack(TIA). Methods 76 patients with coronary heart disease and TIA were randomly divided into test group (n=40) and control group (n=36). The control group was treated with en-teric-coated aspirin 50 mg×2 every night after supper, and the test group was treated with clopidogrel 25 mg×2 and simvastatin 10 mg×2 every night before sleep. Liver and kidney function, blood coagulation function and blood lipids were measured before treatment and after. 1 year followed-up. Results The effective rate was 95.0% (38/40) in test group and 55.5% (20/36) in control group(χ2=6.45,P<0.01). LDL-C was (3.18±1.24) mmol/L and (2.60±1.03)mmol/L(t=2.67,P<0.01),TC was(5.18±1.24) mmol/L and (4.02±2.18) mmol/L(t= 4.91, P<0.01),TG was (1.50±1.02) mmol/L and (1.30±1.03) mmol/L(t=1.02, P>0.05), respectively in test group before and after treatment. However, there was no statistical difference in LDL-C, TC and TG (t=0.17, 0.00,0.52,0.57,P>0.05 for each) in control group. The two groups showed no difference after treatment (t= 1.51,2.55,0.57, P>0.05 for each). Conclusions Glopidogrel combined with simvastatin capsules is safe in pre-vention of TIA attack.